Clinical combined PET/CT radiomics model prediction of benefit from platinum-based chemotherapy and chemoradiotherapy in patients with small cell lung cancer
The clinical combined PET/CT radiomics model can noninvasively and accurately predict the response to platinum-based treatments in SCLC as well as long-term survival prognosis, which can contribute to personalized treatment strategies and guide precision therapy for SCLC patients.
Authors
- Liangqin Zhou
- Fan Ge (ORCID: https://orcid.org/0000-0002-6599-8807)
- Xinyue Yang (ORCID: https://orcid.org/0000-0002-3418-7200)
- Liang Cheng (ORCID: https://orcid.org/0000-0002-6665-6710)
- Kezheng Wang (ORCID: https://orcid.org/0000-0001-8776-5812)
- Mengye Peng
- Wei Liu (ORCID: https://orcid.org/0000-0002-9302-8170)
- Yanmei Wang (ORCID: https://orcid.org/0009-0004-8323-1791)
- Shijia Liu (ORCID: https://orcid.org/0000-0003-0895-8494)
Institutions
- General Electric (United States) (US)
- Harbin Medical University (CN)
- Third Affiliated Hospital of Harbin Medical University (CN)
Publication Details
- Journal
- Nuclear Medicine Communications
- Published
- 2025-03-14
- DOI
- https://doi.org/10.1097/mnm.0000000000001971
- Citations
- 1
- Primary Topic
- Lung Cancer Research Studies
- Type
- article
- Field-Weighted Citation Impact
- 1.05